Orbital Sciences (ORB) Cash Flow Statement

Click line-items for a historical chart and %

Net income	51.54M
Depreciation and amortization expense	31.73M
Deferred income taxes
Stock-based compensation and other	1.75M
Changes in assets and liabilities, net of effect of acquisition	84.26M
Net cash provided by (used in) operating activities	180.43M
Capital expenditures	-24.78M
Payment for business acquisition
Net cash used in investing activities	-14.78M
Net proceeds from issuances of common stock	965K
Debt issuance costs
Tax benefit of stock-based compensation	1.41M
Net cash (used in) provided by financing activities	-3.98M
Net increase (decrease) in cash and cash equivalents	161.66M
Cash and cash equivalents, beginning of period	265.84M
Cash and cash equivalents, end of period	427.5M

Entities mentioned with ORB

View All Entities